Please login to the form below

Not currently logged in
Email:
Password:

Coversyl

This page shows the latest Coversyl news and features for those working in and with pharma, biotech and healthcare.

Lundbeck challenge to EC pay-for-delay ruling fails

Lundbeck challenge to EC pay-for-delay ruling fails

Servier's Coversyl/Aceon (perindopril) that involved four generic drugmakers.

Latest news

  • EU hits Servier and generic firms with €428m 'pay-for-delay' fine EU hits Servier and generic firms with €428m 'pay-for-delay' fine

    Follows deals to delay competition for blood pressure drug Coversyl/Aceon.  . Antitrust authorities in the EU have levied a whopping 428m fine on Servier and several other companies for conspiring to ... in preventing more affordable copies of blood

  • EC fines J&J and Novartis in pay-for-delay case EC fines J&J and Novartis in pay-for-delay case

    Almunia noted that the EC continues to pursue cases against Servier and several generic companies concerning the cardiovascular medicine Coversyl/Aceon (perindopril), as well as Cephalon and Teva concerning narcolepsy treatment

  • EC to investigate Novartis and J&J in antitrust probe EC to investigate Novartis and J&J in antitrust probe

    Antitrust charges have also been laid against Servier and four generic companies in a case involving the French drugmaker's Coversyl/Aceon (perindopril) cardiovascular product and against Lundbeck and eight generics

  • Servier loses patent appeal

    Servier sued Apotex for infringement of its patent for the alpha crystalline form of its ACE inhibitor drug perindopril, sold under the brand name Coversyl. ... Despite losing the case, thanks to an injunction imposed in August 2006 (before the initial

  • Getting the inside track

    There was a substantial gap between Diovan and the second and third placed brands - Coversyl Plus and Zanidip, although generic preparations were not studied in this area.

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics